Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases.

por Rovers, J. P., Schuitmaker, J. J., Vahrmeijer, A. L., van Dierendonck, J. H., Terpstra, O. T.
Publicado 1998

A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.

por Wijsman, J. H., Cornelisse, C. J., Keijzer, R., van de Velde, C. J., van Dierendonck, J. H.
Publicado 1991

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.

por van Slooten, H. J., van de Vijver, M. J., van de Velde, C. J., van Dierendonck, J. H.
Publicado 1998

Effect of hormone depletion on cell survival in the EMR-86 rat mammary carcinoma.

por Wijsman, J. H., Cornelisse, C. J., Keijzer, R., van de Velde, C. J., Elvers, B., van Dierendonck, J. H.
Publicado 1996

Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.

por Marinelli, A., Dijkstra, F. R., van Dierendonck, J. H., Kuppen, P. J., Cornelisse, C. J., van de Velde, C. J.
Publicado 1991

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

por van Slooten, H. J., Bonsing, B. A., Hiller, A. J., Colbern, G. T., van Dierendonck, J. H., Cornelisse, C. J., Smith, H. S.
Publicado 1995

Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.

por Marinelli, A., van Dierendonck, J. H., van Brakel, G. M., Irth, H., Kuppen, P. J., Tjaden, U. R., van de Velde, C. J.
Publicado 1991

B-cell colony growth of malignant and normal B-cells.

por Kluin-Nelemans, J. C., Hakvoort, H. W., van Dierendonck, J. H., Beverstock, G. C., Fibbe, W. E., Willemze, R., van Rood, J. J.
Publicado 1987

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

por Tollenaar, R. A., van Krieken, J. H., van Slooten, H. J., Bruinvels, D. J., Nelemans, K. M., van den Broek, L. J., Hermans, J., van Dierendonck, J. H.
Publicado 1998

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

por van Slooten, H. J., Clahsen, P. C., van Dierendonck, J. H., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroide, A., van de Velde, C. J., van de Vijver, M. J.
Publicado 1996

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with color...

por Vahrmeijer, A L, van Dierendonck, J H, Keizer, H J, Beijnen, J H, Tollenaar, R A E M, Pijl, M E J, Marinelli, A, Kuppen, P J K, van Bockel, J H, Mulder, G J, Velde, C J H van de
Publicado 2000